Effects of phencyclidine (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 22, Issue 1, 1998, Pages 129-146

  Curzon, Peter ^a   Decker, Michael W ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

(+) MK 801; Acoustic startle; Amphetamine; Apomorhine; Mice; Phencyclidine; Prepulse inhibition; Schizophrenia

Indexed keywords

APOMORPHINE; CLOZAPINE; DEXAMPHETAMINE; DIZOCILPINE; DIZOCILPINE MALEATE; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; PRECLAMOL; SIGMA OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG RECEPTOR BINDING; EXPERIMENTAL MODEL; MALE; MOUSE; NONHUMAN; PREPULSE INHIBITION; RECEPTOR BLOCKING; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX; SUBSTANCE ABUSE;

ACOUSTIC STIMULATION; ANIMALS; APOMORPHINE; CLOZAPINE; DEXTROAMPHETAMINE; DIZOCILPINE MALEATE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; MALE; MICE; MICE, INBRED STRAINS; PHENCYCLIDINE; PIPERIDINES; RATS; RECEPTORS, SIGMA; SPECIES SPECIFICITY; STARTLE REACTION;

EID: 0031882712     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(97)00184-X     Document Type: Article

References (36)

1. BAKSHI, V.P. and M.A. GEYER (1993) A pharmacological analysis of PCP-induced deficits in sensorimotor gating of the startle response. Society for Neuroscience Abstracts 19: 598.
2. BOLINO, F., V.D. MICHELLE, L.D. CICCO, V. MANNA, E. DANELUZZO and M. CASACCHIA (1994) Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizphrenia. Biological Psychiatry 36: 670-679.
3. BRAFF, D.L., C. GRILLON and M.A. GEYER (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry 43: 206-215.
4. CADENHEAD, K.S., M.A. GEYER and D.L. BRAFF (1993) Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. American Journal Psychiatry 150: 1862-1867.
5. CLINESCHMIDT, B.V., G.E. MARTIN, P.R. BUNTING and N.L. PAPP (1982) Central sympathomimetic activity of (+)-5-methyl-10,11-dihyro-5h-dibenzo[a,d]cyclohepten-5,10-imine(MK-801), A substance with potent anticonvulsant, central sympathomimetic, and apparent axiolytic properties. Drug Development Research 2: 135-145.
6. COLLINS, A.C., C.B. EVANS, L.L. MINER and M.J. MARKS (1986) Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors. Pharm. Biochem. & Behavior 24: 1767-1773.
7. JAVITT, D.C. (1987) Negative schizophrenic symtomatology and the (PCP) model of schizophrenia. Hillside Journal of Clinical Psychiatry 9: 12-35.
8. JAVITT, D.C. and S.R. ZUKIN (1991) Recent advances in the phencyclidine model of schizophrenia. American Journal Psychiatry 148: 1301-1308.
9. JOHANSSON, C., D.M. JACKSON and L. SVENSSON (1994) The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat. Psychopharmacology 116: 437-442.
10. JOHANSSON, C., D.M. JACKSON, J. ZHANG and L. SVENSSON (1995) Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: Effects of antipsychotics and other agents in rats. Pharmacology Biochemistry & Behavior 52: 649-654.
11. KEITH, V.A., R.S. MANSBACH and M.A. GEYER (1991) Failure of haloperidol to block the effects of phencyclidine and dizoclipine on prepulse inhibition of startle. Biological Psychiatry 30: 557-566.
12. 3H]-1-[1-(2-thienyl)cyclohexyl]piperidide. Journal of Pharmacology & Experimental Therapeutics 238: 739-748.
13. MANSBACH, R.S. (1991) Effects of NMDA receptor ligands on sesorimotor gating in the rat. Eur. J. of Pharmacology 202: 61-66.
14. MANSBACH, R.S. and M.A. GEYER (1989) Effects of phencyclidine and phencycline biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2: 299-308.
15. MANSBACH, R.S., M.A. GEYER and D.L. BRAFF (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94: 507-514.
16. MILLER, C.L., P.-C. BICKFORD, V. LUNTZ-LEYBMAN, L.E. ALDER, G.A. GERHARDT and R. FREEDMAN (1992) Phencyclidine and auditory sensory gating in the hippocampus of the rat. Neuropsychopharmacology 31: 1041-1048.
17. ÖGREN, S.O. and M. GOLDSTEIN (1994) Phencyclidine- and dizoclipine-induced hyperlocomotion are differentially mediated. Neuropsychopharmacology 11: 167-177.
18. OTT, D.A. and R.J. MANDEL (1995) Amphetamine sensitivity in open-field activity vs. the prepulse inhibition paradigm. Brain Research Bulletin 37: 219-222.
19. QUIRION, R., R. CHICHEPORTICHE, P.C. CONTRERAS, K.M. JOHNSON, D. LODGE, S.W. TAM, J.H. WOODS and S.R. ZUKIN (1987) Classification and nomenclature of phencyclidine and sigma receptor sites. Trends in Neurosciences 10: 444-446.
20. RAO, T.S., P.C. CONTRERAS and P.L. WOOD (1990a) Are N-methyl-D-aspartate(NMDA) and phencyclidine (PCP) receptors always functionally coupled to each other? Neurochemistry International 17: 1-8.
21. RAO, T.S., H.S. KIM, J. LEHMANN, L.L. MARTIN and P.L. WOOD (1990b) Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat. Journal of Neurochemistry 54: 1157-1162.
22. RAO, T.S., H.S. KIM, J. LEHMANN, L.L. MARTIN and P.L. WOOD (1990c) Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors. Neuropharmacology 29: 225-230.
23. REID, A.A., J.A. MONN, A.E. JACOBSON, K.C. RICE and R.B. ROTHMAN (1990) Pseudoallosteric modulation by (+)-MK801 of NMDA-coupled phencyclidine sites. Life Sciences 46: pl-77-pl-82.
24. REIJMERS, L.G.J.E., P.M.L. VANDERHEYDEN and B.W.M.M. PEETERS (1995) Changes in prepulse inhibition after local administration of NMDA receptor ligands in the core region of the rat necleus accumbens. European Journal of Pharmacology 272: 131-138.
25. ROTHMAN, R.B., A.A. REID, J.A. MONN, A.E. JACOBSON and K.C. RICE (1989) The psychomimetic drug phencyclidine labels two high affinity binding sties in guinea pig brain: Evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites. Molecular pharmacology 36: 887-896.
26. SNELL, L.D., S.-J. YI and K.M. JOHNSON (1987) Comparison of the effects of MK-801 and phencyclindine on catecholamine uptake and NMDA-induced norepinephrenine release. European Journal of Pharmacology 145: 223-226.
27. SNYDER, S.H. (1988) Psychotogenic drugs as models for schizophrenia. Neuropsychopharmacology 1: 197-199.
28. SONDERS, M.S., J.F.W. KEANA and E. WEBER (1988) Phencyclidine and psychomimetic sigma opiates: recent insights into their biochemical and phyiological sites of action. Trends in Neurosciences 11: 37-40.
29. SUN, X. and A.A. LARSON (1993) MK-801 and Phencyclidine act at phencyclidine sites that are not linked to N-methyl-d-aspartate activity to inhibit behavioral sensitization to kainate. Neuroscience 54: 773-779.
30. SWERDLOW, N.R., D.L. BRAFF, M.A. GEYER and G.F. KOOB (1986) Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol. Psychiatry 21: 23-33.
31. SWERDLOW, N.R., S.B. CAINE and M.A. GEYER (1991) Opiate-dopamine interactions in the neural substrates of acoustic startle gating in the rat. Prog.Neuropsychopharmacology & Biol.Psychiat. 15: 415-426.
32. SWERDLOW, N.R. and M.A. GEYER (1993) Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharm. Biochem. and Behav. 44: 741-744.
33. SWERDLOW, N.R., V.A. KEITH, D.L. BRAFF and M.A. GEYER (1990a) Effects of spiperone, raclopride, SCH 23290 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J. Pharm. Exp. Ther. 256: 530-536.
34. SWERDLOW, N.B., R.S. MANSBACH, M.A. GEYER, L. PULVIRENTI, G.K. KOOB and D.L. BRAFF (1990b) Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology 100: 413-416.
35. 2 receptor antagonist ketanserin. European Journal of Pharmacology 287: 201-205.
36. WILLOTT, J.F. and S. CARLSON (1995) Modification of the acoustic startle response in hearing-impaired C57BL/6J mice: Prepulse augmentation and prolongation of prepulse inhibition. Behavioral Neuroscience 109: 396-403.